Nonsense suppression agent

This page covers all Nonsense suppression agent drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Ribosome (eukaryotic translation machinery).

Targets

Ribosome (eukaryotic translation machinery)

Phase 3 pipeline (1)

• Ataluren (PTC124®) · PTC Therapeutics · Rare genetic diseases
  Ataluren allows ribosomes to read through premature stop codons (nonsense mutations) and produce full-length, functional proteins.

Patent intelligence

• nonsense suppression agent patent landscape — aggregated cliff calendar, attackable patents, originator estates